Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.06 USD | -3.37% | -5.71% | +0.25% |
04-01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
04-01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
Evolution of the average Target Price on Liquidia Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Liquidia Corporation
HC Wainwright | |
BofA Securities | |
Needham & Co. | |
Wedbush | |
Ladenburg Thalmann | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- LQDA Stock
- Consensus Liquidia Corporation